Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
29.88
+0.70 (2.40%)
At close: Jul 14, 2026, 4:00 PM EDT
30.00
+0.12 (0.40%)
After-hours: Jul 14, 2026, 7:00 PM EDT
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.65 billion as of July 14, 2026. Its market cap has increased by 211.28% in one year.
Market Cap
1.65B
Enterprise Value
1.36B
1-Year Change
211.28%
Ranking
Category
Stock Price
$29.88
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.65B, an increase of 141.34%. That is a compound annual growth rate of 83.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.65B | -17.05% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.80B |
| MapLight Therapeutics | 1.78B |
| Hemab Therapeutics Holdings | 1.78B |
| Damora Therapeutics | 1.76B |
| Ascentage Pharma Group International | 1.71B |
| MoonLake Immunotherapeutics | 1.68B |
| Fortrea Holdings | 1.68B |
| Vir Biotechnology | 1.68B |